Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Chronic dosing of oltipraz in people at increased risk for colorectal cancer.

Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ.

Cancer Detect Prev. 2001;25(4):352-61.

PMID:
11531012
2.

Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.

Clapper ML, Szarka CE, Pfeiffer GR, Graham TA, Balshem AM, Litwin S, Goosenberg EB, Frucht H, Engstrom PF.

Clin Cancer Res. 1997 Jan;3(1):25-30.

3.

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

O'Dwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML.

J Clin Invest. 1996 Sep 1;98(5):1210-7.

4.

Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.

Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF, et al.

Cancer Res. 1995 Jul 1;55(13):2789-93.

5.

Palliative Treatment of Esophageal Cancer.

Ahmad NR, Goosenberg EB, Frucht H, Coia LR.

Semin Radiat Oncol. 1994 Jul;4(3):202-214.

PMID:
10717108

Supplemental Content

Loading ...
Support Center